News | December 16, 2025
Anova launches AI-powered patient matching platform to speed clinical trial enrollment
Clinical trial enrollment has long been a bottleneck in drug development
Clinical trial enrollment has long been a bottleneck in drug development
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
The new site marks the company’s first operation in the region
_256_384.jpg)
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Expands bioprocessing footprint across Asia
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The launch of the study was on the occasion of the International Day of Persons with Disabilities
It's an acquisition that aims at forming one of the US's largest oncology trial networks
Subscribe To Our Newsletter & Stay Updated
